Leahy Calls for NIH March-In Against Myriad But Some Patents Not Subject to Bayh-Dole

by jeeg 23. July 2013 22:40
The National Institutes of Health should use its march-in rights under the Bayh-Dole Act to force Myriad Genetics Inc. to license its patents related to testing for genetic mutations associated with breast and ovarian cancer, according to a July 12 letter sent by Sen. Patrick J. Leahy ... [More]
Log in